Meeting
2016 Genitourinary Cancers Symposium
The impact of active smoking on survival outcome in metastatic renal cell carcinoma patients treated with targeted therapy.
Authors
Haoran Li
Tom Baker Cancer Center, Toronto, ON, Canada
Haoran Li , Nils Kroeger , Guillermo de Velasco , Frede Donskov , Hao-Wen Sim , Connor Wells , Igor Stukalin , Neeraj Agarwal , Hiral D. Parekh , Brian I. Rini , Jennifer J. Knox , Allan J. Pantuck , Toni K. Choueiri , Daniel Yick Chin Heng
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 552)
DOI
10.1200/jco.2016.34.2_suppl.552
Abstract #
552
Poster Bd #
F13
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Survival outcomes of metastatic renal cell carcinoma (mRCC) with sarcomatoid differentiation (SD): A single-institutional experience and literature meta-analysis.
First Author: Esmail Mutahar Al-Ezzi
Poster
2022 ASCO Genitourinary Cancers Symposium
The survival outcomes of the metastatic renal cell carcinoma with rhabdoid differentiation in immunotherapy era: Princess Margaret Cancer Center experience.
First Author: Esmail Mutahar Al-Ezzi
Poster
2024 ASCO Annual Meeting
Treatment outcomes of brain metastasis from primary renal cell carcinoma in United States: A National Cancer Database analysis.
First Author: Vivek Podder
Poster
2023 ASCO Genitourinary Cancers Symposium
Genomic alterations in metastatic renal cell carcinoma (mRCC): Impact on survival and clinical outcomes.
First Author: Jennifer King